
WEL Research Institute
Supporting strategic basic research of excellence and the translation of disruptive innovations into an impact in health and sustainable transition.
Supporting strategic basic research of excellence and the translation of disruptive innovations into an impact in health and sustainable transition.
Decio L. Eizirik (WEL Research Institute - ULB) is the recipient of the prestigious George Eisenbarth Memorial Lecture that will be delivered at the 15th annual Network for Pancreatic Organ Donors with Diabetes (nPOD) meeting in Florida, USA.
Sophie Lucas’ team (WEL Research Institute - UCLouvain) showed that the strategy of blocking GARP, a novel immuno-oncology target under clinical investigation for solid cancers, also has potential in "liquid" tumours.
Opening on 15 December 2022 of the first "WEL-T Investigator Programme" call.
⇒ The recording of the Dec 09 information webinar in English is available here.
The WEL Research Institute supports strategic basic research through programmes emanating from the universities of the Wallonia-Brussels Federation. Their selection and financial management are carried out via the FRFS, a specialised fund of the FNRS.
The WEL Research Institute provides individualised support for researchers, in partnership with KTO representatives, to integrate the valorisation process into the scientific development of the research programme.
The Bridge Fund provides funding for a maturation stage of intellectual property emanating from the WEL Research Institute's programmes to reach the next stage of technology transfer.
The WEL Research Institute has gradually built valorization opportunities that are taking many forms including projects supported by the competitivity clusters, licensing agreements, industry partnerships, and spin-off creation.